We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WFC icon
151
Wells Fargo
WFC
$261B
$8.14M 0.14%
183,729
-989
-0.5% -$47.3K
WDAY icon
152
Workday
WDAY
$33.4B
$7.59M 0.13%
82,779
-21,186
-20% -$1.77M
ABBV icon
153
AbbVie
ABBV
$458B
$7.57M 0.13%
120,000
– –
ULTI
154
DELISTED
Ultimate Software Group Inc
ULTI
$6.94M 0.12%
33,966
-8,668
-20% -$1.83M
ATHN
155
DELISTED
Athenahealth, Inc.
ATHN
$6.85M 0.12%
54,334
+1,750
+3% +$223K
PYPL icon
156
PayPal
PYPL
$49.5B
$6.85M 0.12%
167,275
+5,674
+4% +$218K
QCOM icon
157
Qualcomm
QCOM
$176B
$6.85M 0.12%
+100,000
New +$6.08M
SYF icon
158
Synchrony
SYF
$23.7B
$6.72M 0.12%
239,999
-1,261
-0.5% -$34.6K
TD icon
159
Toronto Dominion Bank
TD
$198B
$6.49M 0.11%
125,000
– –
FRC
160
DELISTED
First Republic Bank
FRC
$6.41M 0.11%
83,103
-590
-0.7% -$43.4K
PFLT icon
161
PennantPark Floating Rate Capital
PFLT
$681M
$6.25M 0.11%
472,500
– –
LLY icon
162
Eli Lilly
LLY
$1.07T
$6.02M 0.1%
75,000
– –
BX icon
163
Blackstone
BX
$104B
$5.81M 0.1%
227,583
-2,011
-0.9% -$53.1K
RPD icon
164
Rapid7
RPD
$634M
$5.72M 0.1%
324,604
+69,760
+27% +$1.09M
LLTC
165
DELISTED
Linear Technology Corp
LLTC
$5.49M 0.09%
92,576
-92,576
-50% -$5.19M
BMY icon
166
Bristol-Myers Squibb
BMY
$127B
$5.39M 0.09%
100,000
-605,000
-86% -$38.9M
PNC icon
167
PNC Financial Services
PNC
$100B
$5.39M 0.09%
59,800
– –
GILD icon
168
Gilead Sciences
GILD
$161B
$5.38M 0.09%
68,000
+22,591
+50% +$1.84M
TTWO icon
169
Take-Two Interactive
TTWO
$43B
$5.27M 0.09%
+116,874
New +$4.93M
DFS
170
DELISTED
Discover Financial Services
DFS
$5.23M 0.09%
92,500
– –
USB icon
171
US Bancorp
USB
$99.6B
$5.06M 0.09%
118,009
-577
-0.5% -$24.5K
REGN icon
172
Regeneron Pharmaceuticals
REGN
$68.8B
$5.04M 0.09%
12,550
-1,359
-10% -$545K
BKNG icon
173
Booking.com
BKNG
$138B
$4.91M 0.08%
83,475
+36,250
+77% +$2.02M
UBS icon
174
UBS Group
UBS
$170B
$4.78M 0.08%
345,000
-142,887
-29% -$1.95M
BIIB icon
175
Biogen
BIIB
$29.9B
$4.77M 0.08%
15,250
-4,016
-21% -$1.19M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.